Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -101.43% is 59% below its 5-year average of -63.93%, near the low end of its 5-year range (-117.82%–-29.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.19% below its 12-month average of -98.30%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -101.43%.
RETURN ON INVESTED CAPITAL (ROIC)
-101.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-98.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-71.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-63.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.19%
CURRENT VS 3Y AVG
-42.64%
CURRENT VS 5Y AVG
-58.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
-252.37%
vs the sector median at left
Annexon, Inc.
Market Cap
$688.14M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-98.30%
3Y Avg
-71.11%
5Y Avg
-63.93%
Market Cap
$698.60M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$675.41M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$707.86M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
Market Cap
$709.33M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
9.98%
3Y Avg
8.97%
5Y Avg
8.63%
Market Cap
$719.64M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$643.37M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
Market Cap
$642.31M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$734.10M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | $688.14M | -101.43% | -98.30% | -71.11% | -63.93% |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | -110.62% | -99.41% | -74.42% | -73.36% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -44.30% | -32.94% | -36.44% | -31.30% |
| Helus Pharma Inc. (HELP)vs › | $707.86M | -73.27% | -60.64% | -63.77% | -62.42% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | 6.11% | 9.98% | 8.97% | 8.63% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | N/A | -136.50% | -154.74% | -122.58% |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | -42.02% | -66.01% | -48.82% | -55.42% |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | -20.75% | -20.15% | -33.64% | -24.57% |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | -11.80% | -7.26% | -5.22% | 9.70% |
ROIC
-101.4%
ROE
-108.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -101.43% |
| 2026-03-31 | -90.35% |
| 2025-12-31 | -92.11% |
| 2025-09-30 | -117.82% |
| 2025-06-30 | -89.78% |
| 2025-03-31 | -67.87% |
| 2024-12-31 | -48.21% |
| 2024-09-30 | -36.69% |
| 2024-06-30 | -32.64% |
| 2024-03-31 | -45.05% |
| 2023-12-31 | -51.38% |
| 2023-09-30 | -80.59% |
| 2023-06-30 | -70.52% |
| 2023-03-31 | -61.59% |
| 2022-12-31 | -55.42% |
| 2022-09-30 | -50.04% |
| 2022-06-30 | -72.82% |
| 2022-03-31 | -59.93% |
| 2021-12-31 | -49.27% |
| 2021-09-30 | -39.04% |
| 2021-06-30 | -29.97% |
| 2021-03-31 | -23.95% |
| 2020-12-31 | -18.38% |
| 2020-09-30 | -13.48% |
| 2020-06-30 | -36.22% |
| 2020-03-31 | -117.14% |
| 2019-12-31 | -72.32% |
| 2019-09-30 | -53.05% |
| 2019-06-30 | -75.21% |
| 2018-12-31 | -42.72% |
